Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs

Stem Cells Translational Medicine

Volumn 2, Issue 11, 2013, Pages 916-927

  Linard, Christine ^a   Busson, Elodie ^b   Holler, Valerie ^a   Strup Perrot, Carine ^a   Lacave Lapalun, Jean Victor ^a   Lhomme, Bruno ^a   Prat, Marie ^b   Devauchelle, Patrick ^c   Sabourin, Jean Christophe ^d   Simon, Jean Marc ^e   Bonneau, Michel ^f   Lataillade, Jean Jacques ^b   Benderitter, Marc ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b PERCY MILITARY HOSPITAL   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CEMAGREF   (France)

Author keywords

Cellular therapy; Irradiation; Mesenchymal stem cells; Pig model

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL ASSAY; CELL DIFFERENTIATION; CELL HYPOXIA; CELL ISOLATION; CELL THERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST CULTURE; FLOW CYTOMETRY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROCTITIS; PROTEIN EXPRESSION; RADIATION INJURY; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL EXPANSION; SWINE; TISSUE REPAIR;

SUIDAE;

EID: 84886548407     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0030     Document Type: Article

References (41)

1. Zelefsky MJ, Levin EJ, Hunt M et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124-1129.
2. Eifel PJ, Levenback C, Wharton JT et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995;32:1289-1300.
3. Garg AK, Mai WY, McGary JE et al. Radiation proctopathy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2006;66: 1294-1305.
4. Gilinsky NH, Burns DG, Barbezat GO et al. The natural history of radiation-induced protosigmoiditis: An analysis of 88 patients. Q J Med 1983;52:40-53.
5. Yegappan M, Ho YH, Nyam D et al. The surgical management of colorectal complications from irradiation for carcinoma of the cervix. Ann Acad Med Singapore 1998;27:627-630.
6. Ash D. Lessons from Epinal. Clin Oncol (R Coll Radiol) 2007;19:614-615.
7. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair: Current views. STEM CELLS 2007;25: 2896-2902.
8. Chanda D, Kumar S, Ponnazhagan S. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem 2010;111:249-257.
9. Duijvestein M, Vos AC, Roelofs H et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: Results of a phase I study. Gut 2010;59:1662-1669.
10. Garcia-Olmo D, Herreros D, Pascual I et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial. Dis Colon Rectum 2009;52: 79-86.
11. Gao Z, Zhang Q, Han Y et al. Mesenchymal stromal cell-conditioned medium prevents radiation-induced small intestine injury in mice. Cytotherapy 2012;14:267-273.
12. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
13. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109: 1543-1549.
14. Brittan M, Chance V, Elia G et al. A regenerative role for bone marrow following experimental colitis: Contribution to neovasculogenesis and myofibroblasts. Gastroenterology 2005;128:1984-1995.
15. Andoh A, Bamba S, Fujiyama Y et al. Colonic subepithelial myofibroblasts in mucosal inflammation and repair: Contribution of bone marrow derived stem cells to the gut regenerative response. J Gastroenterol 2005;40: 1089-1099.
16. Sémont A, Mouiseddine M, François A et al. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ 2010;17:952-961.
17. Kudo K, Liu Y, Takahashi K et al. Transplantation of mesenchymal stem cells to prevent radiation-induced intestinal injury in mice. J Radiat Res 2010;51:73-79.
18. Wachter S, Gerstner N, Goldner G et al. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol 2000;54:11-19.
19. Strup-Perrot C, Mathé D, Linard C et al. Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol 2004;287:G875-G885.
20. Komori M, Tsuji S, Tsujii M et al. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen 2005;13:109-118.
21. Bey E, Prat M, Duhamel P et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen 2010;18:50-58.
22. O'Brien PC. Radiation injury of the rectum. Radiother Oncol 2001;60:1-14.
23. Fischer UM, Harting MT, Jimenez F et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 2009;18:683-691.
24. Rochefort GY, Vaudin P, Bonnet N et al. Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: Possibilities of targeting pulmonary artery remodeling via cells therapies? Respir Res 2005;6:125.
25. François S, Bensidhoum M, Mouiseddine M et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: A study of their quantitative distribution after irradiation damage. Stem Cells 2006;24:1020-1029.
26. Badylak SF, Valentin JE, Ravindra AK et al. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008;14:1835-1842.
27. Griffin MD, Ritter T, Mahon BP. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010;21: 1641-1655.
28. Németh K, Leelahavanichkul A, Yuen PS et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009;15:42-49.
29. Cario E. Toll-like receptors in inflammatory bowel diseases: A decade later. Inflamm Bowel Dis 2010;16:1583-1597.
30. Romieu-Mourez R, François M, Boivin MN et al. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 2009;182:7963-7973.
31. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
32. Moodley Y, Atienza D, Manuelpillai U et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009;175:303-313.
33. Taha Y, Raab Y, Larsson A et al. Vascular endothelial growth factor (VEGF): A possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci 2004;49:109-115.
34. Chaudhary NI, Roth GJ, Hilberg F et al. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J 2007;29:976-985.
35. Wu Y, Chen L, Scott PG et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. STEM CELLS 2007;25:2648-2659.
36. Kanazawa S, Tsunoda T, Onuma E et al. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001;96:822-828.
37. Abdollahi A, Li M, Ping G et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 2005; 201:925-935.
38. Hetzel M, Bachem M, Anders D et al. Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 2005;183: 225-237.
39. Lalu MM, McIntyre L, Pugliese C et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and metaanalysis of clinical trials. Canadian Critical Care Trials Group. PLoS One 2012;7:e47559.
40. Rigotti G, Marchi A, Micciolo PR et al. On the safety of autologous fat grafting for breast reconstruction. Plast Reconstr Surg 2012;130: 206e-207e.
41. Voswinkel J, Francois S, Simon JM et al. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: A comprehensive review. Clin Rev Allergy Immunol 2013 [Epub ahead of print].